5 Kawasaki syndrome
5.1.1 Epidemiology
5.1.2 Etiology and pathogenesis
5.2 Clinical findings
5.3 Diagnosis
5.3.1 Laboratory diagnosis
5.3.2 Electrocardiography
5.3.3 Echocardiography
5.3.4 Differential diagnosis
5.4 Treatment
5.4.1 Intravenous immunoglobulin (IVIG)
5.4.2 Acetylsalicylic acid (ASA)
5.4.3 Therapy for treatment-refractory courses
5.5 Prognosis and course
6.1.1 Epidemiology
6.1.2 Etiology and pathogenesis
6.1.3 Histopathology
6.2 Clinical findings
6.3 Diagnosis
6.3.1 Clinical examination
6.3.2 Diagnostic testing
6.3.3 Biopsy/histology
6.3.4 Imaging diagnosis
6.3.5 Differential diagnosis
6.4 Treatment
6.4.1 Initial phase (localized Wegener granulomatosis)
6.4.2 Early systemic phase
6.4.3 Generalization phase
6.4.4 Supportive therapy
6.5 Prognosis and course
7.1.1 Epidemiology
7.1.2 Etiology and pathogenesis
7.2 Clinical findings
7.3 Diagnosis
7.3.1 Clinical examination
7.3.2 Diagnostic testing
7.3.3 Biopsy/histology
7.3.4 Imaging diagnosis
7.3.5 Differential diagnosis
7.4 Treatment
7.5 Prognosis and course
8.1.1 Epidemiology
8.1.2 Etiology and pathogenesis
8.2 Clinical findings
8.3 Diagnosis
8.3.1 Clinical examination
8.3.2 Diagnostic testing
8.3.3 Differential diagnosis
8.4 Treatment
8.4.1 Glucocorticoids
8.4.2 Immunosuppressants
8.4.3 Interferon-α
8.5 Prognosis and course
9.1.1 Etiology and pathogenesis
9.2 Clinical findings
9.3 Diagnosis
9.4 Treatment
9.5 Prognosis and course
10 Cutaneous leukocytoclastic vasculitis
10.2 Clinical findings
10.3 Diagnosis
10.4 Treatment
10.5 Prognosis and course
11.2 Clinical findings
11.3 Diagnosis
11.4 Treatment
11.5 Prognosis
